We are Finalists for a RareVoice Award!
We are thrilled to announce that the Lymphedema Advocacy Group is a finalist for a RareVoice award! This award celebrates and honors advocates and organizations who help amplify the voice
We are thrilled to announce that the Lymphedema Advocacy Group is a finalist for a RareVoice award! This award celebrates and honors advocates and organizations who help amplify the voice
We are deeply saddened to share the news of Bill McCann’s passing. Bill was a member of the Lymphedema Advocacy Group Board of Directors and Co-Chair of our Advocacy Training
In 2006, my son Dylan was born with primary lymphedema. In 2010, I founded the Lymphedema Advocacy Group, with the mission of making sure that all lymphedema patients would someday
My name is Sarah Bramblette. I’m the Board Chair of the Lymphedema Advocacy Group. This year, I’m thankful that the Lymphedema Treatment Act was passed and that, starting January 1
One year ago today, we made lymphedema history – the House of Representatives voted on the Lymphedema Treatment Act (LTA) and it was passed with an astounding bipartisan vote of
Last month, I had the privilege of representing the Lymphedema Advocacy Group at Forward Momentum: Future Steps in Lymphedema Management, hosted by the Lymphology Association of North America (LANA) in
Below is a summary of the LTA final rule. You can read the full 65 pages here. We have also inserted notes into our group’s public comment document, which can
We wanted to send this clarification to assure you that the frequency limitations are based on sets of garments, not individual garments. We apologize that the initial quoted section below
The final rule for implementation of the Lymphedema Treatment Act was just released! The full rule contains a number of different provisions, but you can read the 65 pages related
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

